Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Janux Therapeutics, Inc. | Director | Common Stock | 115K | $6.21M | $53.94 | Nov 5, 2024 | Direct |
Ventyx Biosciences, Inc. | Director | Stock Option (Right to Buy) | 33K | Jun 6, 2024 | Direct | ||
Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 8.35K | Jun 26, 2024 | Direct |